It shouldn't really be a surprise that artificial intelligence (AI) gets a special mention in the long-term plan for the NHS, published in March. AI is seen as important for the future of the NHS because it can make healthcare more effective and efficient, leaving staff free to focus on, as the plan puts it, the'complexity of human interactions that technology will never master'. With a growing population, limited resources yet more and more treatments available, the use of intelligent technology will be key to ensuring our healthcare services can keep pace. At Grow MedTech, we see AI as one of the most important digital technologies that will combine with traditional medtech to create the products and technologies of the future. And Yorkshire is a hotbed for the technology, with all of our partner universities offering expertise in the field.
MedTech Innovator, the premier global nonprofit accelerator in the medical technology industry, today announced the 20 companies selected to participate in the organization's Asia Pacific Showcase program, featuring transformative device, diagnostic, and digital health technologies in the Asia Pacific region. These leading-edge startups, ranging from early- to mid-stage, will receive unparalleled visibility and access to leading manufacturers, providers, inventors and other industry stakeholders that are among the most prominent in the region's medtech ecosystem. MedTech Innovator launched its inaugural MedTech Innovator Asia Pacific Showcase program in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry. "We are thrilled to have expanded the MedTech Innovator program to the Asia Pacific region, where innovation is thriving and many bright entrepreneurs and inventors are staunchly committed to elevating the lives of patients," said Paul Grand, CEO of MedTech Innovator. "These high-caliber startups were selected for the inaugural Asia Pacific program because each is developing a solution that fulfills a significant unmet healthcare need in the region. We look forward to seeing the MedTech Innovator ecosystem grow in Asia Pacific this year, with the goal of advancing life-improving treatments for patients who need them."
San Jose, Sept. 26, 2017 – MedTech Innovator announced today Day Zero Diagnostics as the winner of its 2017 global competition. The Boston-based company was selected in a real-time vote by an audience of nearly 1,500 at The MedTech Conference powered by AdvaMed. This year's winner, Day Zero Diagnostics is combining genome sequencing and machine learning to combat antimicrobial resistant infections, enabling physicians to switch from broad-spectrum antibiotic therapy to a targeted antibiotic in hours rather than days. CEO Jong Lee participated in MedTech Innovator's expansive, customized accelerator program, which included in-depth mentorship from senior leaders in the medtech industry, exclusive networking opportunities, virtual and in-person workshops, and pitching with investors, manufacturers, providers, and customers. "It was a record-breaking year for MedTech Innovator, with no shortage of amazing talent and transformative technologies, and we're thrilled to see Day Zero Diagnostics selected as the 2017 winner," MedTech Innovator CEO Paul Grand said.
Artificial intelligence (AI) is rapidly spreading throughout the realm of medtech as companies from every corner of the market look to adapt to the latest in innovation. Whether you're an industry giant, or a shiny new startup, advancements in AI technologies are forcing companies to embrace and adapt to new developments--all while altering the medtech landscape in the process. How are companies beginning to tap their potential, and when will we begin to actually see the impact they can have on the world of healthcare? These are some of the questions that Gioel Molinari will be addressing at next month's MD&M East 2018 conference in New York, where he'll be part of a panel discussion on the topic of "How Artificial Intelligence is Moving the Needle in Medtech." Molinari is the current president of Butterfly Network Inc., a cutting-edge technology company that focuses on semiconductor technologies, cloud platforms, and artificial intelligence and deep learning technologies that can shape next-gen devices.
Recently I chatted with Candace Roulo, managing editor of Advanced Manufacturing Now, about some of the most important trends in medtech and the technologies that are taking the industry to the next level. Click below to listen to the podcast, or read on for select highlights of the conversation – what I consider to be five trends medtech professionals should be talking about. Advanced Manufacturing Now: You mentioned connectivity. With the healthcare sector embracing the interconnectivity of the Internet of Things for more proactive patient management, what are the opportunities and challenges associated with using sensors in medical devices? And if you could, give us a couple examples of those medical devices.